This role will report to the Deputy Director, Strategy Planning and Management (DDSPM) and be a member of PPP’s Strategy & Implementation Management team.

What You’ll Do This role will partner closely with the PPP leadership team to provide program management, strategy planning, communications, and implementation support for the overall strategy and key initiatives. • Strategy development and execution: Support DDSPM in the execution of the strategy review and annual planning processes; and lead the development of specific deliverables (e.g. investment scoring, execution plans); lead key projects related to strategy, change management, product development, and/or partner management; and provide secondary support for executing and managing large investments as needed. • Portfolio management: Coordinate reporting of progress against strategic goals, milestones and decision points for portfolio review meetings; provide analytic and research support to support decision making; generate portfolio and payment reports to track financial payout of investments funded by the team; implement and monitor action plan for diversity, equity, and inclusion (DEI) and gender integration. • Business operations: Facilitate the team’s rhythm of the business to support management decision-making and resource allocation; coordinate team onboarding with respective hiring managers; identify areas for process optimization and develop solutions to improve team efficiency and productivity; implement foundation and team processes and tools; support Program Coordinator in grant execution and management on an as needed basis; and enable opportunities for continuous learning and knowledge management. • Stakeholder and meeting management: Provide strategy planning and project management support (agenda, materials, facilitation, minutes, follow-up items) to leadership team as needed for team meetings (Program Strategy Team, Staff), initiative meetings, partner convenings, team retreats, and conferences. • Communications: Develop and maintain strategy dissemination materials; support coordination and preparation of materials for external talks, annual planning, and foundation leadership meetings; and serve as a central point of contact for team operations within the foundation.

The Team Our Global Health (GH) Program harnesses advances in science and technology to save lives in poor countries. We focus on the health problems that have a major impact in developing countries but get too little attention and funding. Where proven tools exist, we support sustainable ways to improve their delivery. Where they don’t, we invest in research and development of new interventions, such as vaccines, drugs, biologics, and diagnostics. Our work in infectious diseases focuses on strategies to fight and prevent HIV/AIDS, malaria, tuberculosis, neglected tropical diseases, enteric and diarrheal diseases, and pneumonia. These strategies are supported by functional and cross-cutting teams that focus on Discovery & Translational Sciences, Vaccine Development, Surveillance, Integrated Development, Diagnostics, and Innovation Introduction.

With a focus on low- and middle-income countries (LMICs), the Pneumonia & Pandemic Preparedness (PPP) Team aims to 1) accelerate the reduction in childhood deaths from pneumonia, meningitis, and neonatal sepsis; 2) improve disease surveillance for public health action; 3) minimize mortality and prevent transmission during epidemics and pandemics; and 4) prevent mortality due to antimicrobial resistance (AMR) risk pathogens. We accelerate the development and commercialization of novel and lower-cost vaccines and monoclonal antibodies for our target populations. Our prevention efforts target the following pathogens: pneumococcus, respiratory syncytial virus (RSV), group B streptococcus (GBS), meningococcus, Klebsiella pneumoniae, as well as pandemic influenza and coronaviruses. Given that a growing portion of deaths in young children happen before a child is old enough to be immunized, we are developing vaccines that can be delivered safely during pregnancy (maternal immunization) to protect vulnerable infants during the first months of life through antibodies transferred from their mothers. We also focus on antimicrobial resistance as an increasing global health threat that disproportionately contributes to neonatal sepsis deaths. To guide prioritization of global health interventions, we support surveillance for definitive causes of childhood mortality in LMICs. We also implement and evaluate innovative surveillance approaches and help countries integrate surveillance information for better public health decision-making.